Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
BMC Infectious Diseases|December 7, 2006
Cohort effects in dynamic models and their impact on vaccination programmes: an example from hepatitis AArni S R Srinivasa Rao, Maggie H Chen, Ba' Z Pham, et al.
Preventive Medicine|September 3, 2018
Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesisOvidiu Tatar, Erika Thompson, Anila Naz, et al.
Vaccines|October 27, 2022
Understanding the Impact of Approved but Unfunded Vaccine Status on Parental Acceptance of an Adjuvanted Seasonal Influenza Vaccine for Infants: Results from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)-IIIWilliam A Fisher, Vladimir Gilca, Michelle Murti, et al.
Vaccines|November 24, 2022
Parental Attitudes and Perceptions of Support after Brief Clinician Intervention Predict Intentions to Accept the Adjuvanted Seasonal Influenza Vaccination: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)-IWilliam A Fisher, Vladimir Gilca, Michelle Murti, et al.
Vaccines|November 24, 2022
Clinicians Are Not Able to Infer Parental Intentions to Vaccinate Infants with a Seasonal Influenza Vaccine, and Perhaps They Should Not Try: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)-IVWilliam A Fisher, Vladimir Gilca, Michelle Murti, et al.
Vaccines|January 21, 2023
Continuing Medical Education Improves Physician Communication Skills and Increases Likelihood of Pediatric Vaccination: Findings from the Pediatric Influenza Vaccination Optimization Trial (PIVOT)-IIWilliam A Fisher, Vladimir Gilca, Michelle Murti, et al.
Vaccine|November 24, 2018
Short-term safety of 4CMenB vaccine during a mass meningococcal B vaccination campaign in Quebec, CanadaGaston De Serres, Marie-Noëlle Billard, Marie-Claude Gariépy, et al.
The Journal of Infectious Diseases|August 9, 2012
Cross-reactive and vaccine-induced antibody to an emerging swine-origin variant of influenza A virus subtype H3N2 (H3N2v)Danuta M Skowronski, Naveed Z Janjua, Gaston De Serres, et al.
The Lancet. Infectious Diseases|September 24, 2022
Protection against omicron (B.1.1.529) BA.2 reinfection conferred by primary omicron BA.1 or pre-omicron SARS-CoV-2 infection among health-care workers with and without mRNA vaccination: a test-negative case-control studySara Carazo, Danuta M Skowronski, Marc Brisson, et al.
JAMA Network Open|October 14, 2022
Estimated Protection of Prior SARS-CoV-2 Infection Against Reinfection With the Omicron Variant Among Messenger RNA-Vaccinated and Nonvaccinated Individuals in Quebec, CanadaSara Carazo, Danuta M Skowronski, Marc Brisson, et al.
Pageof 7